Time in Therapeutic Range: Redefining "Optimal" Blood Pressure Control
- PMID: 33706871
- PMCID: PMC8091295
- DOI: 10.1016/j.jacc.2021.01.019
Time in Therapeutic Range: Redefining "Optimal" Blood Pressure Control
Keywords: cardiovascular; hypertension; outcomes variability.
Conflict of interest statement
Funding Support and Author Disclosures Dr. Bakris has received research funding, paid to the University of Chicago, from Bayer and Vascular Dynamics; has served as a consultant for Merck, Vascular Dynamics, Relypsa, Novo Nordisk, AstraZeneca, Ionis, Alnylam, and KBP; has served as bioscience editor for American Journal of Nephrology, Nephrology, and Hypertension; has served as section editor of UpToDate; and has served as associate editor for Diabetes Care, Hypertension Research, and Journal of Nephrology. Dr. Sternlicht has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Systolic Blood Pressure Time in Target Range and Cardiovascular Outcomes in Patients With Hypertension.J Am Coll Cardiol. 2021 Mar 16;77(10):1290-1299. doi: 10.1016/j.jacc.2021.01.014. J Am Coll Cardiol. 2021. PMID: 33706870 Free PMC article. Clinical Trial.
Similar articles
-
Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk.Blood Press Monit. 2007 Dec;12(6):393-5. doi: 10.1097/MBP.0b013e3282f2b53d. Blood Press Monit. 2007. PMID: 18277319
-
Nocturnal Hypertension: Neglected Issue in Comprehensive Hypertension Management.Acta Med Indones. 2016 Jan;48(1):76-82. Acta Med Indones. 2016. PMID: 27241550 Review.
-
Redefining Blood Pressure Assessment - The Role of the Ambulatory Blood Pressure Monitoring Study for Drug Safety.Clin Pharmacol Ther. 2020 Jan;107(1):147-153. doi: 10.1002/cpt.1690. Epub 2019 Nov 30. Clin Pharmacol Ther. 2020. PMID: 31625600 Review.
-
Blood pressure variability, cardiovascular risk and antihypertensive treatment.J Hypertens Suppl. 1995 Dec;13(4):S27-34. doi: 10.1097/00004872-199512002-00005. J Hypertens Suppl. 1995. PMID: 8824684 Review.
-
Letter by Rivasi et al Regarding Article, "Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY)".Circulation. 2020 Mar 24;141(12):e650-e651. doi: 10.1161/CIRCULATIONAHA.119.045048. Epub 2020 Mar 23. Circulation. 2020. PMID: 32202932 No abstract available.
Cited by
-
Is calculation of a home blood pressure-based stability score a tool to improve risk stratification in clinical practice?Hypertens Res. 2024 Nov 14. doi: 10.1038/s41440-024-02021-x. Online ahead of print. Hypertens Res. 2024. PMID: 39543430 No abstract available.
-
The association of out-of-office blood pressure time in target range with clinical outcomes.Hypertens Res. 2024 Sep 27. doi: 10.1038/s41440-024-01918-x. Online ahead of print. Hypertens Res. 2024. PMID: 39333664 No abstract available.
-
Optimizing time-in-target-range assessment for blood pressure: insights from a large-scale study with continual cuffless monitoring.Front Med (Lausanne). 2024 Jun 26;11:1396962. doi: 10.3389/fmed.2024.1396962. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38988353 Free PMC article.
-
Combined effect of time in target range and variability of systolic blood pressure on cardiovascular outcomes and mortality in patients with hypertension: A prospective cohort study.J Clin Hypertens (Greenwich). 2024 Jun;26(6):714-723. doi: 10.1111/jch.14816. Epub 2024 Apr 23. J Clin Hypertens (Greenwich). 2024. PMID: 38651799 Free PMC article.
-
Time in therapeutic range in context of blood pressure management.Hypertens Res. 2024 Jan;47(1):200-202. doi: 10.1038/s41440-023-01457-x. Epub 2023 Oct 11. Hypertens Res. 2024. PMID: 37821566 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
